berberine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases aspartate aminotransferase
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“However, oral administration of BBR not only reversed hepatocyte necrosis, but also decreased the elevated levels of TBA, ALP, TBIL, DBIL, ALT, and AST ( Supplementary Fig. 1A, 1B).”
Quoted verbatim from Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine production.. - Study
- animal · not in humans
- Duration
- 7 days
- Population
- C57BL/6J mice with bile duct ligation-induced cholestatic liver injury; serum AST by automated biochemical analyser
Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine production.2026PMID:41087029Permalink
Keep reading
- Everything the graph holds on berberine
- Every compound studied against Aspartate aminotransferase
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M0Z5JBM02R24BX6871TRWMFQ